ProSomnus Data Shows Effectiveness of Precision Oral Appliance Therapy for Sleep Apnea Treatment

By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA) announced the presentation of three abstracts at the 2023 SLEEP Annual Meeting, demonstrating the effectiveness and safety of their Precision Oral Appliance Therapy (OAT) devices for treating Obstructive Sleep Apnea (OSA), the company...